Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride for GERD with incomplete PPI response
NCT03676374Phase 4Unknown
- Sponsor
- UZ Leuven
- Start
- Feb 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prucalopride in gastroesophageal reflux disease (GERD), sponsored by UZ Leuven. Status: unknown.
02
Drugs
prucalopride
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03676374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676374.